Ortho-k ready for success, but cost too high, says GlobalData

Article

Orthokeratology has re-emerged as a treatment for myopia, however, its high price tag may hinder its adoption in the corrective vision market.

 

London-Orthokeratology has re-emerged as a treatment for myopia and hyperopia, according to Joseph Gregory, an analyst with research and consulting firm GlobalData. Gregory added that, while the technology provides an intermediate solution between existing interventions, its high price tag may hinder its adoption in the corrective vision market.

Developed in the 1960s, orthokeratology uses rigid contact lenses that are worn at night to reshape the cornea and temporarily reduce a person’s refractive error. These contact lenses cost approximately $700, a significantly higher price than refractive surgery or soft contact lenses.

“While orthokeratology provides an intermediate solution between invasive and non-invasive interventions, the price of the lenses needs to be substantially lower than it is currently, especially with the corrective vision market being sensitive to economic conditions and consumer confidence,” Gregory said.

"LASIK surgery is a prime example of this. Prior to the most recent recession, there were U.S. procedure volumes of 1.4 million in 2007. Three years later, that figure decreased to 800,000 and it has not recovered since,” he added.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD, and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
© 2025 MJH Life Sciences

All rights reserved.